Literature DB >> 15260476

Backbone dynamics of the RNase H domain of HIV-1 reverse transcriptase.

Geoffrey A Mueller1, Koteppa Pari, Eugene F DeRose, Thomas W Kirby, Robert E London.   

Abstract

Previous NMR relaxation studies of the isolated RNase H domain of HIV-1 reverse transcriptase at low pH have revealed that it is substantially more dynamic and less ordered than the relatively stable and catalytically active E. coli RNase HI. Using more recently developed techniques, we have investigated the dynamic behavior of the RNase H domain of HIV-1 reverse transcriptase at a more physiological pH (6.8), under a variety of solution conditions: no Mg(2+), 80 mM Mg(2+), and 80 mM Mg(2+) plus AMP ligand. In addition, we have repeated the previous measurements on a sample containing 100 mM sodium acetate, pH 5.4. Under all conditions studied, the order parameters from NMR relaxation analysis are uniformly high (>0.8) for most of the domain with the exception of the C-terminal region. Subtle differences can be found among the conditions studied, although the statistical significance of the differences is marginal. Residues 71-114 show a slight increase in order parameter with the addition of 5'-AMP. Conformational exchange, measured with CPMG relaxation dispersion experiments in the presence of Mg and AMP, were detected for some NH sites, predominantly located in the N-terminal region of the protein near strands beta2 and beta3 and helix alpha(A) (residues 28-69). In contrast with earlier studies indicating pathologically extreme dynamic behavior that apparently correlated with inactivity of the isolated domain, the relaxation analysis under the conditions of the present study yielded parameters that are more similar to those of the active E. coli RNase HI. A comparison of the order parameters obtained from a model-free analysis of the relaxation data with the B-factors in the crystal structures of the RNase H domain, both for the isolated domain and for the full HIV-1 reverse transcriptase structure, suggests that the dynamic behavior is similar in all cases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15260476     DOI: 10.1021/bi049555n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  Nucleotide docking: prediction of reactant state complexes for ribonuclease enzymes.

Authors:  Brigitta Elsässer; Gregor Fels
Journal:  J Mol Model       Date:  2010-12-01       Impact factor: 1.810

Review 2.  Functional aspects of protein flexibility.

Authors:  Kaare Teilum; Johan G Olsen; Birthe B Kragelund
Journal:  Cell Mol Life Sci       Date:  2009-03-24       Impact factor: 9.261

3.  Expression of an Mg2+-dependent HIV-1 RNase H construct for drug screening.

Authors:  Richard V Farias; Deborah A Vargas; Andres E Castillo; Beatriz Valenzuela; Marie L Coté; Monica J Roth; Oscar Leon
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

4.  Entire-Dataset Analysis of NMR Fast-Exchange Titration Spectra: A Mg2+ Titration Analysis for HIV-1 Ribonuclease H Domain.

Authors:  Ichhuk Karki; Martin T Christen; Justin Spiriti; Ryan L Slack; Masayuki Oda; Kenji Kanaori; Daniel M Zuckerman; Rieko Ishima
Journal:  J Phys Chem B       Date:  2016-12-05       Impact factor: 2.991

5.  Combinatorial selection, inhibition, and antiviral activity of DNA thioaptamers targeting the RNase H domain of HIV-1 reverse transcriptase.

Authors:  Anoma Somasunderam; Monique R Ferguson; Daniel R Rojo; Varatharasa Thiviyanathan; Xin Li; William A O'Brien; David G Gorenstein
Journal:  Biochemistry       Date:  2005-08-02       Impact factor: 3.162

6.  Determinants of Active-Site Inhibitor Interaction with HIV-1 RNase H.

Authors:  Zhaoyong Xi; Zhengqiang Wang; Stefan G Sarafianos; Nataliya S Myshakina; Rieko Ishima
Journal:  ACS Infect Dis       Date:  2019-10-02       Impact factor: 5.084

7.  Solution structural dynamics of HIV-1 reverse transcriptase heterodimer.

Authors:  James M Seckler; Kathryn J Howard; Mary D Barkley; Patrick L Wintrode
Journal:  Biochemistry       Date:  2009-08-18       Impact factor: 3.162

8.  The p66 immature precursor of HIV-1 reverse transcriptase.

Authors:  Naima G Sharaf; Eric Poliner; Ryan L Slack; Martin T Christen; In-Ja L Byeon; Michael A Parniak; Angela M Gronenborn; Rieko Ishima
Journal:  Proteins       Date:  2014-05-12

9.  Structural basis of the allosteric inhibitor interaction on the HIV-1 reverse transcriptase RNase H domain.

Authors:  Martin T Christen; Lakshmi Menon; Nataliya S Myshakina; Jinwoo Ahn; Michael A Parniak; Rieko Ishima
Journal:  Chem Biol Drug Des       Date:  2012-08-31       Impact factor: 2.817

10.  Unfolding the HIV-1 reverse transcriptase RNase H domain--how to lose a molecular tug-of-war.

Authors:  Xunhai Zheng; Lars C Pedersen; Scott A Gabel; Geoffrey A Mueller; Eugene F DeRose; Robert E London
Journal:  Nucleic Acids Res       Date:  2016-01-14       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.